ClinConnect ClinConnect Logo
Search / Trial NCT05656560

Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial

Launched by NORTHWESTERN UNIVERSITY · Dec 9, 2022

Trial Information

Current as of June 23, 2025

Active, not recruiting

Keywords

Clinical Decision Support Electronic Health Record Behavioral Economics High Risk Geriatric Polypharmacy

ClinConnect Summary

The "Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial" is studying how to help doctors safely manage medications for older adults, especially those with dementia or memory problems. Many older patients take multiple medications, which can lead to serious issues like side effects or falls. This trial will test two different reminders (or "nudges") in electronic health records that encourage doctors to think carefully about their patients' prescriptions. Over 18 months, some clinics will use these nudges, while others will not, to see if this approach helps reduce risky medication use.

To participate in this trial, patients must be seen at specific primary care clinics, like Internal Medicine or Geriatrics, associated with Northwestern Medicine or UPMC. The trial is currently active but not recruiting new participants. During the study, doctors will share their experiences with these nudges to understand how helpful they are and if they fit well into their daily work. This research is important because it aims to improve medication safety for older adults, making healthcare safer and more effective.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Northwestern Medicine or UPMC primary care clinic: Internal Medicine, Family Medicine, or General Practice or Geriatrics
  • Exclusion Criteria:
  • None

About Northwestern University

Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.

Locations

Pittsburgh, Pennsylvania, United States

Chicago, Illinois, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials